Cargando…
The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson’s Disease: What We Know and Where to Go
Cardiovascular autonomic dysfunctions (CAD) are prevalent in Parkinson’s disease (PD). It contributes to the development of cognitive dysfunction, falls and even mortality. Significant progress has been achieved in the last decade. However, the underlying mechanisms and effective treatments for CAD...
Autores principales: | Zhu, Shuzhen, Li, Hualing, Xu, Xiaoyan, Luo, Yuqi, Deng, Bin, Guo, Xingfang, Guo, Yang, Yang, Wucheng, Wei, Xiaobo, Wang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460297/ https://www.ncbi.nlm.nih.gov/pubmed/34631214 http://dx.doi.org/10.14336/AD.2021.0214 |
Ejemplares similares
-
Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go
por: Qin, Weida, et al.
Publicado: (2022) -
Resistance in tuberculosis: what do we know and where can we go?
por: Green, Keith D., et al.
Publicado: (2013) -
Hearing Loss and Cognition: What We Know and Where We Need to Go
por: Powell, Danielle S., et al.
Publicado: (2022) -
Impulsive dispositions and alcohol: what we know, how we know it, and where to go from here
por: Stevens, Angela K., et al.
Publicado: (2018) -
Spinal cord injury and neurogenic lower urinary tract dysfunction:
what do we know and where are we going?
por: Dodd, William, et al.
Publicado: (2022)